Over the course of his 15-year career, Dr. Heacock says that heâs âlong recognized that there is a significant percentage of patients for whom we have never been able to offer meaningful relief.â
In his experience, these patients tend to have extensive trauma histories and traditional modes of treatment sometimes come up short. He says he believes treatment-resistant disorders, more often than not, are âtied to a deep, and largely untouchable, river of trauma that lies beneath our reach in the unconscious mind.â
And while this is not a new perspective for somatic trauma therapists, psychedelic treatment appears to be âa less painful portal to accessing the interface of the unconscious and the body,â he writes.
From adaptogens to psychedelics: What s next for wellness mushroom obsession – Glossy glossy.co - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from glossy.co Daily Mail and Mail on Sunday newspapers.
DEC 21, 2020
After successfully traveling through the niche wellness-to-mainstream pipeline, mushrooms are set to get more “magical” with the prospect of wider legalization of psychedelics.
An adaptogen craze went mass in 2020; consumers can find mushrooms in just about anything these days, including supplements, coffee, tea, jerky and even beauty products. The global functional mushroom market is said to be worth $23 billion this year, with a projected compound annual growth rate of 5.6% over the next five years. With currently legal mushrooms being touted for their health benefits, the recent news on psychedelic legalization in Oregon has mushroom-related wellness startups closely watching the shroom opportunity on the horizon.
DEA Hit With Another Lawsuit From Scientists Seeking to Research Cannabis
DEA Hit With Another Lawsuit From Scientists Seeking to Research Cannabis
The time is nigh for the DEA to cooperate in ensuring that medical marijuana research can move forward. Finally.
On December 3, 2020, MAPS (the Multidisciplinary Association for Psychedelic Studies) issued a press release regarding a lawsuit filed against the DEA and the Attorney General to “compel issuance of licenses to manufacture marijuana for clinical trials and potential FDA approval.” We have written about MAPS and its 35 years of advocacy and engagement with DEA before, and we are big fans of the nonprofit.
A trip to better management skills?
More and more Israeli senior executives are discovering the benefits and perils of mind-altering drugs.
The substances described in this article are illegal in Israel and their use, even in a controlled manner, may cause physiological and mental disorders. About three years ago I turned 50 and decided to give myself a present, says Eyal, a senior executive at a global corporation. I took a month off from work and decided to go on a two-week retreat with a famous shaman in Peru - to encounter all that I thought I would be and hadn’t fulfilled. When I arrived, I saw no white people, except me. A tubby, pleasant person took me to a hostel where people from all over the world had already gathered - all business people who want to connect with themselves. For some of them, this was not the first time.